Clinical Trial Update: A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes a combination therapy strategy to prevent resistance to anti-PD-1 therapy in metastatic ovarian cancer; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Anti-PD-1 therapy

Snippet

Sponsor: Georgetown University | Conditions: Ovarian Cancer Stage IV, Ovarian Cancer Stage III | Phase 2 | Status: NOT_YET_RECRUITING